MX2018004217A - Tetrahidropiranilsulfonas sustituidas con pirazolilo. - Google Patents
Tetrahidropiranilsulfonas sustituidas con pirazolilo.Info
- Publication number
- MX2018004217A MX2018004217A MX2018004217A MX2018004217A MX2018004217A MX 2018004217 A MX2018004217 A MX 2018004217A MX 2018004217 A MX2018004217 A MX 2018004217A MX 2018004217 A MX2018004217 A MX 2018004217A MX 2018004217 A MX2018004217 A MX 2018004217A
- Authority
- MX
- Mexico
- Prior art keywords
- pyrazolyl substituted
- tetrahydropyranylsulfones
- compounds
- substituted tetrahydropyranylsulfones
- pyrazolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención se refiere a tetrahidropiranilsulfonas sustituidas con pirazolilo como bloqueadores de los canales de calcio dependientes de voltaje, a composiciones farmacéuticas que contienen estos compuestos y también a estos compuestos para utilizar en el tratamiento y/o profilaxis del dolor y de otras enfermedades y/o trastornos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15002880 | 2015-10-08 | ||
PCT/EP2016/025108 WO2017059966A1 (en) | 2015-10-08 | 2016-10-07 | Pyrazolyl substituted tetrahydropyranylsulfones |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018004217A true MX2018004217A (es) | 2018-06-13 |
Family
ID=54293015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018004217A MX2018004217A (es) | 2015-10-08 | 2016-10-07 | Tetrahidropiranilsulfonas sustituidas con pirazolilo. |
Country Status (11)
Country | Link |
---|---|
US (1) | US10100041B2 (es) |
JP (1) | JP2018530569A (es) |
CN (1) | CN108473480A (es) |
AR (1) | AR106295A1 (es) |
AU (1) | AU2016336777A1 (es) |
BR (1) | BR112018007004A2 (es) |
CA (1) | CA3001949A1 (es) |
HK (1) | HK1258461A1 (es) |
MX (1) | MX2018004217A (es) |
TW (1) | TW201726128A (es) |
WO (1) | WO2017059966A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3470406A1 (en) | 2014-04-14 | 2019-04-17 | Grünenthal GmbH | Aryl substituted heterocyclyl sulfones |
JP6673850B2 (ja) | 2014-04-14 | 2020-03-25 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | ヘテロアリール置換されたヘテロシクリルスルホン |
TW201718557A (zh) | 2015-10-08 | 2017-06-01 | 歌林達有限公司 | 經吡唑基取代之四氫吡喃基碸 |
IL298694A (en) * | 2019-10-18 | 2023-02-01 | Fmc Corp | Method for preparing 5-bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrallose-3-carboxylic acid |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007125398A2 (en) | 2006-04-27 | 2007-11-08 | Pfizer Japan Inc. | : sulfonamide compounds as antagonists of the n-type calcium channel |
EP2158183A2 (en) * | 2007-05-25 | 2010-03-03 | Vertex Pharmaceuticals Incorporated | Ion channel modulators and methods of use |
GB0813142D0 (en) | 2008-07-17 | 2008-08-27 | Glaxo Group Ltd | Novel compounds |
EP2477963A4 (en) | 2009-09-18 | 2013-02-27 | Zalicus Pharmaceuticals Ltd | ARYLSULFON DERIVATIVES AS CALCIUM CHANNEL BLOCKERS |
EP2885293B1 (en) * | 2012-08-16 | 2016-07-27 | Janssen Pharmaceutica, N.V. | Substituted pyrazoles as n-type calcium channel blockers |
BR112015003393A2 (pt) * | 2012-08-16 | 2017-07-04 | Janssen Pharmaceutica Nv | pirazóis substituídos como bloqueadores de canal de cálcio de tipo-n |
TW201416348A (zh) * | 2012-08-29 | 2014-05-01 | Gruenenthal Chemie | 以氟甲基取代之吡咯甲醯胺 |
EP3470406A1 (en) * | 2014-04-14 | 2019-04-17 | Grünenthal GmbH | Aryl substituted heterocyclyl sulfones |
JP6673850B2 (ja) * | 2014-04-14 | 2020-03-25 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | ヘテロアリール置換されたヘテロシクリルスルホン |
TW201718557A (zh) | 2015-10-08 | 2017-06-01 | 歌林達有限公司 | 經吡唑基取代之四氫吡喃基碸 |
-
2016
- 2016-10-06 TW TW105132386A patent/TW201726128A/zh unknown
- 2016-10-07 JP JP2018517899A patent/JP2018530569A/ja not_active Withdrawn
- 2016-10-07 CN CN201680062218.7A patent/CN108473480A/zh active Pending
- 2016-10-07 BR BR112018007004A patent/BR112018007004A2/pt not_active Application Discontinuation
- 2016-10-07 CA CA3001949A patent/CA3001949A1/en not_active Abandoned
- 2016-10-07 US US15/288,009 patent/US10100041B2/en not_active Expired - Fee Related
- 2016-10-07 AU AU2016336777A patent/AU2016336777A1/en not_active Abandoned
- 2016-10-07 AR ARP160103076A patent/AR106295A1/es unknown
- 2016-10-07 MX MX2018004217A patent/MX2018004217A/es unknown
- 2016-10-07 WO PCT/EP2016/025108 patent/WO2017059966A1/en active Application Filing
-
2019
- 2019-01-16 HK HK19100766.1A patent/HK1258461A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US10100041B2 (en) | 2018-10-16 |
CN108473480A (zh) | 2018-08-31 |
TW201726128A (zh) | 2017-08-01 |
CA3001949A1 (en) | 2017-04-13 |
BR112018007004A2 (pt) | 2018-10-16 |
JP2018530569A (ja) | 2018-10-18 |
AR106295A1 (es) | 2018-01-03 |
WO2017059966A1 (en) | 2017-04-13 |
US20170101398A1 (en) | 2017-04-13 |
AU2016336777A1 (en) | 2018-04-12 |
HK1258461A1 (zh) | 2019-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016013447A (es) | Heterociclilsulfonas heteroarilo sustituidas. | |
PH12020500500A1 (en) | Pyrazolopyrimidinone compounds and uses thereof | |
MX2021009673A (es) | Moduladores de ror-gamma. | |
MX2018004220A (es) | Tetrahidropiranilsulfonas sustituidas con pirazolilo. | |
MX2017013562A (es) | Reguladores de microbioma y usos relacionados de los mismos. | |
MX2017005834A (es) | Polinucleotidos aad para el tratamiento de la enfermedad de parkinson. | |
PH12019502363A1 (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
MX2017006437A (es) | Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor. | |
MX2018002446A (es) | Compuestos heterociclicos fusionados como moduladores s1p. | |
MX2013002118A (es) | 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
MX2018004217A (es) | Tetrahidropiranilsulfonas sustituidas con pirazolilo. | |
MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
MX2020009966A (es) | Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina. | |
MY191337A (en) | Compositions for the treatment of hypertension and/or fibrosis | |
MX2017013772A (es) | Conjugados mezclados de disulfuro de compuestos de tienopiridina y usos de los mismos. | |
PH12018500886A1 (en) | Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders | |
MX2016013451A (es) | Heterociclilsulfonas arilo sustituidas. | |
MX2016007955A (es) | Pirrol carboxamidas iii fluorometil-sustituidas. | |
PH12017501694A1 (en) | Compositions for the treatment of fibrosis and fibrosis-related diseases | |
PH12016502480A1 (en) | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | |
MX2016007951A (es) | Pirrol carboxamidas iv fluorometil-sustituidas. | |
MX2016007956A (es) | Pirrol carboxamidas fluorometil-sustituidas como bloqueadores del canal de calcio de cav2.2. | |
MX2013002295A (es) | 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
MX2018006631A (es) | Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas. | |
MX2018004774A (es) | Derivados de morfolina sustituidos que tienen actividad contra el dolor. |